Istituto di Ricerca e Innovazione Biomedica, Consiglio Nazionale delle Ricerche (CNR), Via Ugo La Malfa 153, 90146, Palermo, Italy.
Consiglio Nazionale delle Ricerche (CNR), Istituto di Farmacologia Traslazionale, 00133, Rome, Italy.
Inflammation. 2024 Feb;47(1):74-83. doi: 10.1007/s10753-023-01894-3. Epub 2023 Aug 29.
The present study was conceived to examine the effects of inhibition of BMS-345541 mediated IKK kinase phosphorylation on the cellular defence system as well as on anti-inflammatory response and HSP90 activity. The analysis was conducted in A549 cell line, since such cells carry a homozygous Keap1 mutation (G333C) that alters its interaction with Nrf2. Recent data have highlighted that Keap1, HSP90 protein and IKK kinase interact reciprocally and particularly Keap1 protein is involved in HSP90 and anti-oxidative pathway regulation. The activities of COX2 and HO1 were investigated by real time and immunoblot analysis along with the synthesis and activity of inducible forms of heat shock protein HSP90. Pre-treatment with IKK kinase inhibitor proved to be a protective means to lower the activity of inflammatory cascade, so preventing the formation of excessive amounts of pro-inflammatory molecules. The inhibitor of IKK kinase BMS-345541 was added to cultured A549 cells before the Escherichia coli lipopolysaccharide (LPS) addition. The viability of the cells was determined after 1-24 h incubation with BMS-345541 at concentrations ranging from 1,25-5 µM. It was found that 1 µM concentration does not significantly affected cell viability (data not shown). As a result, the treatment with 1 μM of BMS-345541 induces the inhibition of IKK phosphorylation. In the A549 cells treated with BMS-345541 and LPS, COX2 activity is not induced: mRNA and protein levels have not increased, while there is an increase in the level of HSP90, HO1 proteins and mRNA. The results suggest that the IKK inhibition is effective in the reduction of the inflammatory response thanks to mechanisms involving both the heat shock cellular defense system and the antioxidative pathway.
本研究旨在探讨抑制 BMS-345541 介导的 IKK 激酶磷酸化对细胞防御系统以及抗炎反应和 HSP90 活性的影响。该分析在 A549 细胞系中进行,因为这些细胞携带一个导致其与 Nrf2 相互作用改变的 Keap1 纯合突变(G333C)。最近的数据强调了 Keap1、HSP90 蛋白和 IKK 激酶之间相互作用,特别是 Keap1 蛋白参与 HSP90 和抗氧化途径的调节。通过实时和免疫印迹分析以及诱导型热休克蛋白 HSP90 的合成和活性研究 COX2 和 HO1 的活性。IKK 激酶抑制剂的预处理被证明是一种降低炎症级联活性的保护手段,从而防止形成过多的促炎分子。在加入大肠杆菌脂多糖(LPS)之前,将 IKK 激酶抑制剂 BMS-345541 添加到培养的 A549 细胞中。在浓度为 1、25-5µM 的 BMS-345541 孵育 1-24 小时后,测定细胞活力。结果发现 1µM 浓度不会显著影响细胞活力(未显示数据)。因此,用 1µM 的 BMS-345541 处理会抑制 IKK 磷酸化。在用 BMS-345541 和 LPS 处理的 A549 细胞中,COX2 活性未被诱导:mRNA 和蛋白质水平没有增加,而 HSP90、HO1 蛋白和 mRNA 水平增加。结果表明,IKK 抑制通过涉及细胞热应激防御系统和抗氧化途径的机制有效降低炎症反应。